Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of IV Clofarabine in MDS Post-5-azacytidine Failure
NCT00700011Phase 2Terminated
- Sponsor
- Texas Oncology
- Start
- Mar 2008
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in myelodysplastic syndrome (MDS), sponsored by Texas Oncology. Started Mar 2008; status: terminated.
02
Drugs
clofarabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00700011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700011.